CIK 0000200406
- Large accelerated filer
JOHNSON & JOHNSON
Sign in to watch- Ticker
- JNJ
- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- FY end
- Jan 3
- Incorporated
- NJ
- Entity type
- Operating
- EIN
- 221024240
- Phone
- +1 732-524-2455
- Business address
- ONE JOHNSON & JOHNSON PLZ, NEW BRUNSWICK, NJ, 08933
- Former names
- JOHNSON & JOHNSON ET AL
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market buy Director bought 1,250 shares at $206.15 ($257,688)
- 4 Open-market sale 10% owner sold 6,337 shares at $10.03 ($63,560)
- 4 Open-market sale 10% owner sold 2,700 shares at an average $10.05 ($27,132)
- 4 Open-market sale 10% owner sold 1,000 shares at $10.00 ($10,000)
- 4 Open-market sale 10% owner sold 52,532 shares at an average $10.21 ($536,310)
- 4 Open-market sale EVP, Innovative Medicine, R&D sold 21,721 shares at $192.71 ($4,185,793)
- 3 Insider Initial Statement of Ownership
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market sale EVP, WWC. Innovative Medicine sold 56,471 shares at $177.81 ($10,040,883)
- 4 Shares withheld for taxes Executive VP, General Counsel gave up 9,570 shares (to pay taxes)
- 4 Open-market sale CEO and Chairman of the Board sold 125,824 shares at $179.21 ($22,548,655)
- 4 Open-market sale Exec VP, CFO sold 16,820 shares at $176.91 ($2,975,571)
- 4 Open-market sale EVP, Innovative Medicine, R&D sold 19,137 shares at $163.55 ($3,129,830)
- 3 Insider Initial Statement of Ownership
- 4 Derivatives Options or other derivatives
Page 4 of 98 · 1,944 filings